FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $711,000 | -18.1% | 12,000 | +20.0% | 8.60% | -37.1% |
| Q2 2021 | $868,000 | +31.5% | 10,000 | +25.0% | 13.69% | +28.4% |
| Q1 2021 | $660,000 | +123.7% | 8,000 | +146.9% | 10.66% | +131.9% |
| Q4 2020 | $295,000 | -95.2% | 3,240 | -97.9% | 4.60% | -21.2% |
| Q3 2020 | $6,127,000 | +14.8% | 153,297 | -1.4% | 5.84% | -0.2% |
| Q2 2020 | $5,335,000 | +49.2% | 155,505 | -3.4% | 5.85% | +35.2% |
| Q1 2020 | $3,575,000 | +12.8% | 160,959 | -0.6% | 4.33% | +4.1% |
| Q4 2019 | $3,170,000 | +172.1% | 161,977 | +116.0% | 4.16% | +283.4% |
| Q3 2019 | $1,165,000 | – | 75,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
| Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
| Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
| DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
| Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
| Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
| Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
| Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
| Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |